-
UPDATE: BTIG Initiates Coverage On Pharmacyclics
Tuesday, January 6, 2015 - 8:38am | 230Read More...BTIG initiated coverage on Pharmacyclics, Inc. (NASDAQ: PCYC) Monday with a Buy rating and $225 price target. Analyst Hartaj Singh believed the “current valuation is a reflection of consensus inadequately modelling the rapid and broad uptake of ibrutinib in various liquid tumors. We are...
-
BTIG Initiates Coverage On Sunesis Pharmaceuticals, Believes Company 'Will Be Breakeven By 2017'
Monday, January 5, 2015 - 8:19pm | 264Read More...BTIG initiated coverage on Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) Monday with a Buy rating and $5.50 price target. Analyst Hartaj Singh believed the “current valuation reflects the Street assuming a 15-20 percent probability of vosaroxin approval in the US and EU. We believe the...
-
UPDATE: BTIG Initiates Coverage On United Therapeutics
Monday, January 5, 2015 - 8:14pm | 179Read More...BTIG initiated coverage on United Therapeutics Corporation (NASDAQ: UTHR) Monday with a Neutral rating. Analyst Hartaj Singh believed a “late-2017 patent cliff for 3 out of 4 of its top products that could reduce 2018 adjusted EPS to 2013 levels (~$6-7/share) is offset by the blue sky...
-
BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies
Monday, January 5, 2015 - 8:11pm | 182Read More...BTIG initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Monday with a Buy rating and $200 price target. Analyst Hartaj Singh believed “that [the] current valuation is not indicative of the significant potential for combination Kalydeco/lumacaftor therapy in cystic...
-
Why BTIG Downgraded Procter & Gamble
Tuesday, December 30, 2014 - 9:11am | 137Read More...April Scee of BTIG downgraded Procter & Gamble Co (NYSE: PG) to Neutral on Tuesday after shares traded above the firm's $92 price target. According to Scee, shares of Procter & Gamble have outperformed some of its peers throughout 2014. The analyst notes that the company's "Hundred Brand...
-
BTIG Raises Price Target On Lending Club, Sees Consumer Shift
Monday, December 15, 2014 - 3:11pm | 236Read More...BTIG raised its price target on Lending Club Corporation (NYSE: LC) from $19 to $31 and reiterated its Buy rating. Analyst Mark Palmer “observed that during the company’s pre-IPO venture-round capital raises, its valuation was consistently between 0.8x and 0.9x its total origination...
-
BTIG Cites Value In Zayo Group Downgrade
Thursday, December 11, 2014 - 6:42pm | 186Read More...Zayo Group Holdings Inc (NYSE: ZAYO), up nearly 39 percent since its October initial public offering and an analyst said Thursday it's valuation has become too rich. BTIG's Walter Piecyk downgraded Zayo to Neutral, from Buy, and said although he's "generally adverse" to...
-
BTIG Comments On Keurig Green Mountain After Q4 Report
Thursday, November 20, 2014 - 2:30pm | 172Read More...BTIG commented on Keurig Green Mountain Inc (NASDAQ: GMCR) Thursday after the company beat Q4 earnings estimates. Analyst Theo Brito noted that "Keurig delivered stronger Q4 topline & margins (reported EBITA +26 percent y/y) thanks to acceleration in higher-margin portion-pack sales...
-
Keurig Green Mountain Q4 Earnings Preview
Wednesday, November 19, 2014 - 4:20pm | 209Read More...Keurig Green Mountain Inc (NASDAQ: GMCR) reports FY Q4 earnings Wednesday after the close. The company is estimated to report EPS of $0.77 on revenue of $1.16 billion. Bank of America analyst Bryan D. Spillane forecasted EPS of $0.77, in line with consensus. “We are forecasting sales...
-
Genworth Financial Down 37%; Compass Point Downgrades
Thursday, November 6, 2014 - 4:09pm | 292Read More...Genworth Financial Inc (NYSE: GNW) shocked the market with a $531 million addition to its long-term care reserves Thursday and news that a similar review for its active life business won't be complete until after the fourth quarter. "The market will shoot first and ask questions later...
-
BTIG: Hologic To Gain From Higher 3D Mammogram Reimbursements
Monday, November 3, 2014 - 2:31pm | 225Read More...Hologic, Inc. (NASDAQ: HOLX) hit a gusher with new Medicare reimbursement rates for its three-dimensional mammography imaging technology. Rates unveiled Monday by the federal Centers for Medicare & Medicaid Services came in at the high end of investors' expectations, BTIG's Sean...
-
BTIG Likes What It Saw At Intuitive Surgical Conference
Tuesday, October 28, 2014 - 2:17pm | 242Read More...In a note from research firm BTIG, Sean Lavin M.D provides insights from the Technology Forum hosted by Intuitive Surgical, Inc. (NASDAQ: ISRG). "The event was oversubscribed: Since this conference is mainly attended by general surgeons, we see this attendance as a lead indicator for...
-
UPDATE: BTIG Upgrades Intuitive Surgical
Wednesday, October 22, 2014 - 9:08am | 164Read More...In a note released Wednesday morning, BTIG analyst Sean Lavin upgraded shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) from Neutral to Buy and announced a $585 price target. In light of Intuitive's earnings release on Tuesday, Lavin commented, "Though shares may not trade up a whole...
-
BTIG Issues 'Anti-Preview' On Consumer Staples With Short-Term Convictions
Wednesday, October 8, 2014 - 3:15pm | 390Read More...BTIG issued a September-Q "Anti-Preview" on Wednesday. The report expected a weak quarter with a short-term risk/reward for some stocks. Analyst April Scee noted she believed September-Q estimates "are at risk...on (1) slower Asia & Latin America, (2) weak US mass market, (3...
-
UPDATE: BTIG Initiates Coverage On DISH Network Corp
Friday, October 3, 2014 - 10:42am | 127Read More...In a note released Friday, BTIG analyst Walter Piecyk initiated coverage of DISH Network Corp (NASDAQ: DISH) with a Buy rating and a $85 price target. Piecyk commented, "We believe the strategic value of Dish's spectrum will be on the rise in 2015 as wireless operators in the United...

